For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The aim of Selçuk Çolak’s research is to gain more insight into therapy resistance in colorectal cancer, and to identify novel forms of treatment. He looks at the variation between patients and cell heterogeneity within tumours to increase our understanding of why tumours recur and how we can prevent this regrowth. Cell heterogeneity is largely down to the existence of a small population of so-called cancer stem cells (CSCs) that drive tumour growth and resist therapy. Unravelling why these CSCs are resistant to therapy can help to develop therapies targeting these specific cells.

Event details of Targeting cancer stem cells
Date 16 June 2016
Time 16:00 -17:00
Location Agnietenkapel
Room Location

S. Çolak: Targeting Cancer Stem Cells. Modulating Apoptosis and Stemness.

Supervisor

Prof. J.P. Medema

Co-supervisor

Prof. G.R. van den Brink

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.